bmaher.bsky.social
News featured editor at Nature. bmaher.01 on signal.
108 posts
4,417 followers
318 following
Prolific Poster
Conversation Starter
comment in response to
post
“The annual revenue generated by the global legal trade in wildlife (CITES and non-CITES) in total has been estimated at USD 220 billion”
cites.org/eng/news/fir...
comment in response to
post
@amyaconroy.bsky.social minced no words when she described the impacts the NIH cuts to trials abroad will have.
“This trial is the product of five years of formative work that American taxpayers have invested in, and they will never know the results of this study that they’ve paid for.”
comment in response to
post
To be clear I am crediting the original @emilykennard.bsky.social @margaretmanto.bsky.social story, NYT followed that up. www.notus.org/health-scien...
comment in response to
post
Industry groups are scrambling. 'Re-branding' is an option: Cancer vaccines could be 'neo-antigen therapy,' or simply 'immune therapy'. But it's likely some will relocate their businesses, or just shift focus. “It’s ugly out there,” says Ipsita Smolinski, director of DC-based Capitol Street. (5/5)
comment in response to
post
People in the industry are already feeling the effects. Nearly 50% of senior life-scientists who responded to a survey said that they were seeing impacts of policy changes related to mRNA grants. (4/n)
comment in response to
post
There have been legal challenges to the vaccines' approval status. Some grants were cancelled dozens related to the tech were compiled into a 'data call' list by the NIH, suggesting that they will be re-evaluated and possibly terminated. www.nature.com/articles/d41... (3/n)
comment in response to
post
Trump was the one who helped propel these vaccines to prominence through Operation Warp Speed. Instead of highlighting his success, his supporters have questioned the treatments' well-established safety record and spread misinformation. Not unexpected given who he put in charge at HHS. (2/n)
comment in response to
post
Nevertheless, some sources for this story in @nature.com are optimistic. Forced to be self-sufficient in the fight against AIDS, some countries may find ways to cope with the blows issued this year, and maybe salvage some of the amazing progress made in the past 20. www.nature.com/articles/d41...
comment in response to
post
World leaders have been taking their foot off the gas in this fight. Complacency is an issue as many have forgotten how bad AIDS can be. Eric Goosby, former US AIDS global coordinator, says we're about to get a reminder
comment in response to
post
International funding cuts were already slowing the pace of progress toward a 90% reduction in deaths and new infections by 2030 (from 2010 levels). But cuts, especially to USAID and PEPFAR, are risking a huge resurgence in caseload and mortality.